3Murphy M T, Wilkoff B L. What internists should know about amiodarone. Cleve Clin J Med, 1998, 65: 159-166. 被引量：1
4Sager P T, Uppal P, Follmer C, et al. Frequency de pendent electrophysiologic effects of amiodarone in humans. Circulation, 1993,88:1063-1071. 被引量：1
5Heny F, Clomo M D, PhD Mark A, et al. Intraverous amiodarone for acute heart rate control in the critically ill patient with atrial tachyarhythmias. J Am Cardiol, 1998,81:594-598. 被引量：1
6Hou Z Y, Chang M S, Chen C Y. Acute treatment of recent onset atrial fibrillation and flutter with a tailored dosing regime of intraverous amiodarone. Eur Heart J, 1995,16:521-528. 被引量：1
7Ott MC, Khoor A, Leventhal JP, et al. Pulmonary toxicity in patients receiving low-dose amiodarone [J] . Chest, 2003, 123 (2) : 646 -651. 被引量：1
6Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST elevation myocardial infarction executive summary. Can J Cardiol, 2004,20 ( 10 ) : 977 -1025. 被引量：1
8Wetzel U, Boldt A, Lauschke J, et al. Expression of connexins 40 and 43 in human left atrium in atrial fibrillation of different aetiologies. Heart, 2005,91 ( 2 ) : 166-170. 被引量：1
9Madrid AH, Escobar C, Rebollo JM, et al. Angiotensin receptor blocker as adjunctive therapy for rhythm control in atrial fibrillation: results of the irbesartan-amiodarone trial. Card Electrophysiol Rev, 2003,7 ( 3 ) : 243-246. 被引量：1
